Royal Bank Of Canada V Tv Therapeutics Inc. Transaction History

Royal Bank Of Canada

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.42 - $0.75 $77 - $138	184 Added 168.81%	293 $0
Q2 2023 Aug 14, 2023	SELL	$0.72 - $0.95 $267 - $353	-372 Reduced 77.34%	109 $0
Q1 2023 May 15, 2023	BUY	$0.72 - $1.01 $259 - $364	361 Added 300.83%	481 $0
Q4 2022 Feb 14, 2023	SELL	$0.66 - $40.8 $34 - $2,162	-53 Reduced 30.64%	120 $0
Q3 2022 Nov 14, 2022	BUY	$0.65 - $38.8 $28 - $1,707	44 Added 34.11%	173 $0
Q2 2022 Aug 15, 2022	SELL	$0.39 - $0.84 $16 - $36	-43 Reduced 25.0%	129 $0
Q1 2022 May 16, 2022	SELL	$0.51 - $1.0 $4 - $9	-9 Reduced 4.97%	172 $0
Q4 2021 Feb 14, 2022	BUY	$0.95 - $1.69 $14 - $25	15 Added 9.04%	181 $0
Q3 2021 Nov 15, 2021	SELL	$1.53 - $2.22 $716 - $1,038	-468 Reduced 73.82%	166 $0
Q2 2021 Aug 16, 2021	BUY	$2.27 - $3.44 $1,439 - $2,180	634 New	634 $1,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.1B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.